Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe clinical considerations relevant to the choice of an optimal initial HBV treatment strategy for HBeAg-positive patients
- Explain the latest clinical data and best practices regarding treatment strategies for treatment-naive HBeAg-positive patients with chronic hepatitis B
- Cite differences in on-treatment monitoring and managing of HBeAg-positive patients with chronic hepatitis B
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.